Listen to this podcast with clinical and managed care pharmacy expert perspectives on the use of available and emerging subcutaneous immunotherapy options for patients with cancer.

An audio podcast with expert insights on what oncology pharmacists need to know to safely and effectively incorporate ADCs into solid tumor management.

Listen in as a respiratory diseases expert and radiology expert discuss the pathophysiology of non–cystic fibrosis bronchiectasis (NCFBE), the patient burden, and best practices with diagnosing NCFBE.

Listen in as Jonathan A. Bernstein, MD, and Ryan Haumschild, PharmD, MS, MBA, CPEL, discuss approaches to managing systemic mastocytosis—from earlier recognition and diagnosis to the use of emerging targeted therapies—that can reduce disease burden and improve outcomes for patients.

Listen to Allison Butts, PharmD, BCOP, review key highlights from a virtual live webinar on optimal approaches to ensure that comprehensive patient-centric care is provided for patients with HR+/HER2- metastatic breast cancer and various other comorbidities.

In this episode, Jessica Davis, PharmD, and Alexa Basilio, PharmD, explore the complexities of immune-related toxicities, offering expert insights on how to monitor, treat, and prevent these adverse events.

Listen as Su Wang, MD, MPH, FACP; Richard R. Andrews, MD, MPH; Ruth Brogden, MPH; and Amy S. Tang, MD, explore how early and sustained HBV care can be enhanced by expanding the role of primary care providers.

Listen as Mark S. Sulkowski, MD, FIDSA, FAASLD; Tatyana Kushner, MD, MSCE; Paul Y. Kwo, MD; and patient advocate Jacki Chen, PhD, review strategies for more expansive HBV treatment while considering adverse events, cost-effectiveness, and patient perspectives.

Listen as Douglas Dieterich, MD; Camilla S. Graham, MD, MPH; and Robert Wong, MD, MS, review barriers to and strategies for adopting new recommendations on universal HBV screening for all adults and best practices for screening of all patients with chronic HBV infection for HDV in the United States.

Hear Julie Ann Justo, PharmD, MS, FIDSA, BCPS, share her approach to treating CRE infections through a patient case, including a review of the changing epidemiology of CRE, contributing mechanisms of resistance, and current IDSA guidance recommendations based on the latest data.